Skip to main content

Table 2 Patient characteristics by exposure status

From: Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study

Characteristics Patient was on pazopanib
N = 23
Patient was not on pazopanib
N = 182
p
Age, years
 Mean + SD 40.63 + 3.23 43. 81 + 1.45 0.456
Gender
 Male 11 (48%) 95 (52%)  
 Female 12 (52%) 87 (48%) 0.693
Race
 White 18 (78%) 122 (67%)  
 African American 3 (13%) 21 (12%)  
 Hispanic/other 2 (9%) 39 (21%) 0.355
Cavitary lung nodules/masses
 Yes 10 (43%) 52 (29%)  
 No 13 (57%) 130 (71%) 0.142
Pleural-based lung nodules/masses
 Yes 14 (61%) 83 (46%)  
 No 9 (39%) 99 (54%) 0.167
Emphysema present
 Yes 0 (0%) 3 (2%)  
 No 23 (100%) 179 (98%) 0.535
Prior radiation to the chest
 Yes 0 (0%) 3 (2%)  
 No 23 (100%) 179 (98%) 0.535
Patient developed pneumothorax
 Yes 8 (35%) 33 (18%)  
 No 15 (65%) 149 (82%) 0.060